加齢黄斑変性症治療薬の世界市場 2020年

• 英文タイトル：Global Age Related Macular Degeneration Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201100344 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、加齢黄斑変性症治療薬の世界市場を調査対象にし、加齢黄斑変性症治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ルセンティス、アイリー、アバスチン、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Regeneron Pharmaceuticals、Roche、Bayer HealthCare、Novartis、Kanghong Pharma ・メーカー別販売量、売上、市場シェア ・加齢黄斑変性症治療薬の地域別市場分析 ・加齢黄斑変性症治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・加齢黄斑変性症治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・加齢黄斑変性症治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・加齢黄斑変性症治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・加齢黄斑変性症治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・加齢黄斑変性症治療薬の種類別市場規模2015-2020：ルセンティス、アイリー、アバスチン、その他 ・加齢黄斑変性症治療薬の用途別市場規模2015-2020：病院、クリニック、その他 ・加齢黄斑変性症治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論

Market Overview
The Age Related Macular Degeneration Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Age Related Macular Degeneration Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.6%% in the forecast period of 2020 to 2025 and will expected to reach USD 8789.4 million by 2025, from USD 7055.7 million in 2019.

Market segmentation
Age Related Macular Degeneration Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Age Related Macular Degeneration Drug market has been segmented into
Lucentis
Eylea
Avastin
Other

By Application, Age Related Macular Degeneration Drug has been segmented into:
Hospitals
Clinics
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Age Related Macular Degeneration Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Age Related Macular Degeneration Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Age Related Macular Degeneration Drug market.

The report offers in-depth assessment of the growth and other aspects of the Age Related Macular Degeneration Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Age Related Macular Degeneration Drug Market Share Analysis
Age Related Macular Degeneration Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Age Related Macular Degeneration Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Age Related Macular Degeneration Drug sales, revenue and market share for each player covered in this report.

The major players covered in Age Related Macular Degeneration Drug are:
Regeneron Pharmaceuticals
Roche
Bayer HealthCare
Novartis
Kanghong Pharma

Among other players domestic and global, Age Related Macular Degeneration Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Age Related Macular Degeneration Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Age Related Macular Degeneration Drug, with price, sales, revenue and global market share of Age Related Macular Degeneration Drug in 2018 and 2019.
Chapter 3, the Age Related Macular Degeneration Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Age Related Macular Degeneration Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Age Related Macular Degeneration Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Age Related Macular Degeneration Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Age Related Macular Degeneration Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Age Related Macular Degeneration Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Age Related Macular Degeneration Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Overview of Global Age Related Macular Degeneration Drug Market
1.4.1 Global Age Related Macular Degeneration Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Regeneron Pharmaceuticals
2.1.1 Regeneron Pharmaceuticals Details
2.1.2 Regeneron Pharmaceuticals Major Business
2.1.3 Regeneron Pharmaceuticals SWOT Analysis
2.1.4 Regeneron Pharmaceuticals Product and Services
2.1.5 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer HealthCare
2.3.1 Bayer HealthCare Details
2.3.2 Bayer HealthCare Major Business
2.3.3 Bayer HealthCare SWOT Analysis
2.3.4 Bayer HealthCare Product and Services
2.3.5 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Kanghong Pharma
2.5.1 Kanghong Pharma Details
2.5.2 Kanghong Pharma Major Business
2.5.3 Kanghong Pharma SWOT Analysis
2.5.4 Kanghong Pharma Product and Services
2.5.5 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Age Related Macular Degeneration Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Age Related Macular Degeneration Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Age Related Macular Degeneration Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Age Related Macular Degeneration Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
4.3 Europe Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
4.5 South America Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Country
5.1.1 North America Age Related Macular Degeneration Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Age Related Macular Degeneration Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
5.3 Canada Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Age Related Macular Degeneration Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Age Related Macular Degeneration Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
6.3 UK Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
6.4 France Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
6.5 Russia Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
6.6 Italy Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Age Related Macular Degeneration Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Age Related Macular Degeneration Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
7.3 Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
7.4 Korea Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
7.5 India Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
7.7 Australia Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Country
8.1.1 South America Age Related Macular Degeneration Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Age Related Macular Degeneration Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Age Related Macular Degeneration Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Age Related Macular Degeneration Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Age Related Macular Degeneration Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Age Related Macular Degeneration Drug Sales and Market Share by Type (2015-2020)
10.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Age Related Macular Degeneration Drug Price by Type (2015-2020)
11 Global Age Related Macular Degeneration Drug Market Segment by Application
11.1 Global Age Related Macular Degeneration Drug Sales Market Share by Application (2015-2020)
11.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2015-2020)
11.3 Global Age Related Macular Degeneration Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Age Related Macular Degeneration Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Age Related Macular Degeneration Drug Market Forecast (2021-2025)
12.2.2 Europe Age Related Macular Degeneration Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Age Related Macular Degeneration Drug Market Forecast (2021-2025)
12.2.4 South America Age Related Macular Degeneration Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Age Related Macular Degeneration Drug Market Forecast (2021-2025)
12.3 Age Related Macular Degeneration Drug Market Forecast by Type (2021-2025)
12.3.1 Global Age Related Macular Degeneration Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Age Related Macular Degeneration Drug Market Share Forecast by Type (2021-2025)
12.4 Age Related Macular Degeneration Drug Market Forecast by Application (2021-2025)
12.4.1 Global Age Related Macular Degeneration Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Age Related Macular Degeneration Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Age Related Macular Degeneration Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Age Related Macular Degeneration Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Age Related Macular Degeneration Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Age Related Macular Degeneration Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Major Business
Table 10. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Total Revenue (USD Million) (2018-2019)
Table 11. Regeneron Pharmaceuticals SWOT Analysis
Table 12. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product and Services
Table 13. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Roche Basic Information, Manufacturing Base and Competitors
Table 15. Roche Age Related Macular Degeneration Drug Major Business
Table 16. Roche Age Related Macular Degeneration Drug Total Revenue (USD Million) (2018-2019)
Table 17. Roche SWOT Analysis
Table 18. Roche Age Related Macular Degeneration Drug Product and Services
Table 19. Roche Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 21. Bayer HealthCare Age Related Macular Degeneration Drug Major Business
Table 22. Bayer HealthCare Age Related Macular Degeneration Drug Total Revenue (USD Million) (2018-2019)
Table 23. Bayer HealthCare SWOT Analysis
Table 24. Bayer HealthCare Age Related Macular Degeneration Drug Product and Services
Table 25. Bayer HealthCare Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Novartis Basic Information, Manufacturing Base and Competitors
Table 27. Novartis Age Related Macular Degeneration Drug Major Business
Table 28. Novartis Age Related Macular Degeneration Drug Total Revenue (USD Million) (2018-2019)
Table 29. Novartis SWOT Analysis
Table 30. Novartis Age Related Macular Degeneration Drug Product and Services
Table 31. Novartis Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Kanghong Pharma Basic Information, Manufacturing Base and Competitors
Table 33. Kanghong Pharma Age Related Macular Degeneration Drug Major Business
Table 34. Kanghong Pharma Age Related Macular Degeneration Drug Total Revenue (USD Million) (2018-2019)
Table 35. Kanghong Pharma SWOT Analysis
Table 36. Kanghong Pharma Age Related Macular Degeneration Drug Product and Services
Table 37. Kanghong Pharma Age Related Macular Degeneration Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Global Age Related Macular Degeneration Drug Sales by Manufacturer (2018-2019) (K Units)
Table 39. Global Age Related Macular Degeneration Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 40. Global Age Related Macular Degeneration Drug Sales by Regions (2015-2020) (K Units)
Table 41. Global Age Related Macular Degeneration Drug Sales Market Share by Regions (2015-2020)
Table 42. Global Age Related Macular Degeneration Drug Revenue by Regions (2015-2020) (USD Million)
Table 43. North America Age Related Macular Degeneration Drug Sales by Countries (2015-2020) (K Units)
Table 44. North America Age Related Macular Degeneration Drug Sales Market Share by Countries (2015-2020)
Table 45. North America Age Related Macular Degeneration Drug Revenue by Countries (2015-2020) (USD Million)
Table 46. North America Age Related Macular Degeneration Drug Revenue Market Share by Countries (2015-2020)
Table 47. Europe Age Related Macular Degeneration Drug Sales by Countries (2015-2020) (K Units)
Table 48. Europe Age Related Macular Degeneration Drug Sales Market Share by Countries (2015-2020)
Table 49. Europe Age Related Macular Degeneration Drug Revenue by Countries (2015-2020) (USD Million)
Table 50. Asia-Pacific Age Related Macular Degeneration Drug Sales by Regions (2015-2020) (K Units)
Table 51. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share by Regions (2015-2020)
Table 52. Asia-Pacific Age Related Macular Degeneration Drug Revenue by Regions (2015-2020) (USD Million)
Table 53. South America Age Related Macular Degeneration Drug Sales by Countries (2015-2020) (K Units)
Table 54. South America Age Related Macular Degeneration Drug Sales Market Share by Countries (2015-2020)
Table 55. South America Age Related Macular Degeneration Drug Revenue by Countries (2015-2020) (USD Million)
Table 56. South America Age Related Macular Degeneration Drug Revenue Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Age Related Macular Degeneration Drug Sales by Countries (2015-2020) (K Units)
Table 58. Middle East & Africa Age Related Macular Degeneration Drug Sales Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Age Related Macular Degeneration Drug Revenue by Countries (2015-2020) (USD Million)
Table 60. Middle East & Africa Age Related Macular Degeneration Drug Revenue Market Share by Countries (2015-2020)
Table 61. Global Age Related Macular Degeneration Drug Sales by Type (2015-2020) (K Units)
Table 62. Global Age Related Macular Degeneration Drug Sales Share by Type (2015-2020)
Table 63. Global Age Related Macular Degeneration Drug Revenue by Type (2015-2020) (USD Million)
Table 64. Global Age Related Macular Degeneration Drug Revenue Share by Type (2015-2020)
Table 65. Global Age Related Macular Degeneration Drug Sales by Application (2015-2020) (K Units)
Table 66. Global Age Related Macular Degeneration Drug Sales Share by Application (2015-2020)
Table 67. Global Age Related Macular Degeneration Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 68. Global Age Related Macular Degeneration Drug Market Share Forecast by Regions (2021-2025)
Table 69. Global Age Related Macular Degeneration Drug Sales Forecast by Type (2021-2025) (K Units)
Table 70. Global Age Related Macular Degeneration Drug Market Share Forecast by Type (2021-2025)
Table 71. Global Age Related Macular Degeneration Drug Sales Forecast by Application (2021-2025)
Table 72. Global Age Related Macular Degeneration Drug Market Share Forecast by Application (2021-2025)
Table 73. Direct Channel Pros & Cons
Table 74. Indirect Channel Pros & Cons
Table 75. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Age Related Macular Degeneration Drug Picture
Figure 2. Global Sales Market Share of Age Related Macular Degeneration Drug by Type in 2019
Figure 3. Lucentis Picture
Figure 4. Eylea Picture
Figure 5. Avastin Picture
Figure 6. Other Picture
Figure 7. Age Related Macular Degeneration Drug Sales Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Other Picture
Figure 11. Global Age Related Macular Degeneration Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Age Related Macular Degeneration Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Age Related Macular Degeneration Drug Sales Market Share by Manufacturer in 2019
Figure 32. Global Age Related Macular Degeneration Drug Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Age Related Macular Degeneration Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Age Related Macular Degeneration Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Age Related Macular Degeneration Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Age Related Macular Degeneration Drug Revenue Market Share by Regions (2015-2020)
Figure 39. Global Age Related Macular Degeneration Drug Revenue Market Share by Regions in 2018
Figure 40. North America Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
Figure 41. Europe Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
Figure 43. South America Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020)
Figure 45. North America Age Related Macular Degeneration Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Age Related Macular Degeneration Drug Sales Market Share by Countries (2015-2020)
Figure 47. North America Age Related Macular Degeneration Drug Sales Market Share by Countries in 2018
Figure 48. North America Age Related Macular Degeneration Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Age Related Macular Degeneration Drug Revenue Market Share by Countries in 2018
Figure 50. United States Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Age Related Macular Degeneration Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Age Related Macular Degeneration Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Age Related Macular Degeneration Drug Revenue Market Share by Countries in 2019
Figure 56. Germany Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Age Related Macular Degeneration Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Age Related Macular Degeneration Drug Revenue Market Share by Regions 2019
Figure 64. China Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Age Related Macular Degeneration Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Age Related Macular Degeneration Drug Sales Market Share by Countries in 2019
Figure 71. South America Age Related Macular Degeneration Drug Revenue Market Share by Countries in 2019
Figure 72. Brazil Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Age Related Macular Degeneration Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Age Related Macular Degeneration Drug Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Age Related Macular Degeneration Drug Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Age Related Macular Degeneration Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Age Related Macular Degeneration Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Age Related Macular Degeneration Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Age Related Macular Degeneration Drug Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Age Related Macular Degeneration Drug Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Age Related Macular Degeneration Drug Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Age Related Macular Degeneration Drug Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Age Related Macular Degeneration Drug Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel

---